Spots Global Cancer Trial Database for Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy
Official Title: Remote Outpatient Temperature Monitoring for Early Detection of Febrile Neutropenia After Chemotherapy
Study ID: NCT04081753
Conditions
Interventions
Study Description
Brief Summary: Febrile neutropenic patients are at high risk for developing sepsis and other infections which often necessitates acute admission to the Intensive Care Unit (ICU) and are associated with high mortality. Neutropenic fever is a medical emergency and early detection of fever allows for prompt infectious work up. In this study, the investigators will collect pilot data from outpatients utilizing a remote outpatient continuous temperature monitoring device to compare the incidence of ICU admission and severe sepsis to historical data for prior patients who did not receive at home monitoring device.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Augusta University Medical Center, Augusta, Georgia, United States
Contact Details
Name: Locke J. Bryan, MD
Affiliation: Augusta University
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
